Australia's most trusted
source of pharma news
Friday, 05 December 2025
Posted 5 December 2025 AM
A new, subcutaneous formulation of Roche’s Ocrevus will slash treatment times for thousands of multiple sclerosis (MS) patients after being listed on the PBS.
Twice-yearly injections with Ocrevus SC take just 10 minutes. Infusions with Ocrevus IV, which has been PBS listed since 2018, are also twice yearly but take between two and three-and-a-half hours.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.